Oligometastases: Defined by prognosis and evaluated by cure
Authors:
- Hiroyuki KanedaHKHiroyuki Kaneda
- Yukihito SaitoYSYukihito Saito
Open Access
- 1 January 2015
- journal article
- Published by Elsevier in Cancer Treatment Communications
- Vol. 3, 1-6
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Role of stereotactic body radiotherapy for oligometastasis from colorectal cancerWorld Journal of Gastroenterology, 2014
- Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancerWorld Journal of Gastroenterology, 2014
- Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic modelAnnals of Oncology, 2012
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trialThe Lancet Oncology, 2012
- Needle-Tract Seeding After Percutaneous Cryoablation for Lung Metastasis of Colorectal CancerThe Annals of Thoracic Surgery, 2011
- A survey of stereotactic body radiotherapy use in the United StatesCancer, 2011
- Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled TrialsJournal of Clinical Oncology, 2008
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- Oligometastases.Journal of Clinical Oncology, 1995